Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | IDO1 | P14902 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.48 |
| ▸ | MLKL | Q8NB16 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KLK7 | P49862 | 1/20 | 0.42 |
| ▸ | OGA | O60502 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | BCHE | P06276 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28722124 | 0.88 | MAPT (0.52) | MAPTPOLBIDO1ALDH1A1TAAR1 | |
| SCHEMBL4933877 | 0.87 | BCHE (0.53) | MAPTPOLBIDO1ALDH1A1TAAR1 | |
| SCHEMBL4155864 | 0.75 | MAPT (0.46) | MAPTPOLBIDO1ALDH1A1TAAR1 | |
| SCHEMBL4148419 | 0.74 | OPRM1 (0.50) | MAPTPOLBIDO1ALDH1A1MLKL | |
| SCHEMBL4150713 | 0.74 | OPRL1 (0.50) | MAPTPOLBIDO1ALDH1A1TAAR1 | |
| SCHEMBL30665026 | 0.73 | ALDH1A1 (0.66) | POLBIDO1ALDH1A1TAAR1MLKL | |
| SCHEMBL2147079 | 0.73 | ALDH1A1 (0.66) | POLBIDO1ALDH1A1TAAR1MLKL | |
| SCHEMBL85832 | 0.73 | ALDH1A1 (0.66) | POLBIDO1ALDH1A1TAAR1MLKL | |
| SCHEMBL5321876 | 0.73 | TAAR1 (0.48) | MAPTPOLBIDO1ALDH1A1TAAR1 | |
| SCHEMBL5329879 | 0.73 | IDO1 (0.46) | MAPTPOLBIDO1ALDH1A1TAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080280933-A1 | BENZIMIDAZOLYL COMPOUNDS | EFREMOV IVAN | 2008-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080280933-A1 | BENZIMIDAZOLYL COMPOUNDS | PAICS, TMBIM6, ABCG2 | MAPT 2472/4885POLB 2835/4885IDO1 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.